# FDA 483 - Nomax Inc - February 01, 2018

Source: https://www.keypedia.com/records/483/nomax-inc/f9b1be40-af0b-4f69-ae37-dc2c793bcebb

> FDA 483 for Nomax Inc on February 01, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nomax Inc
- Inspection Date: 2018-02-01
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: Nomax, Inc. in Saint Louis, Missouri, was inspected by the FDA from January 23 to February 1, 2018, as a human drug manufacturer. The inspection revealed significant issues related to equipment cleaning and maintenance, as well as inadequate procedures for the annual visual examination of reserve drug product samples for deterioration. These findings indicate a moderate level of non-compliance with good manufacturing practices.

## Related Documents

- [WARNING_LETTER - 2016-10-27](https://www.keypedia.com/records/warning_letter/nomax-inc/79e9daea-cca5-4615-8ae9-1abad26ab361)
- [EIR - 2018-02-01](https://www.keypedia.com/records/eir/nomax-inc/19e7ce70-e68b-4393-add1-72957061c091)
- [483 - 2022-12-02](https://www.keypedia.com/records/483/nomax-inc/de5c4f0a-98b8-443a-8ec6-d20401f7ffb5)

## Related Officers

- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)

Company: https://www.keypedia.com/companies/nomax-inc/269d696c-bdf9-48a2-9ce3-2ba71aef35aa

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8